Generalized Anxiety Disorder (GAD)

Core Idea

Generalized Anxiety Disorder is characterized by persistent, excessive, difficult-to-control worry about multiple life domains lasting at least six months. Individuals experience hyperarousal, difficulty concentrating, sleep disturbance, and muscle tension. GAD often co-occurs with depression; core cognitive factors include threat overestimation and intolerance of uncertainty. Treatment addresses both worry content and the metacognitive processes maintaining it.

Explainer

From your overview of anxiety disorders, you know that anxiety becomes disordered when the fear response is disproportionate to actual threat, occurs without clear triggers, and impairs functioning. GAD has a distinctive profile among anxiety disorders: the anxiety is not tied to a specific object or situation (as in phobias), not organized around panic (as in panic disorder), and not provoked by specific triggers like social evaluation or contamination. Instead, the defining feature is free-floating worry — a restless, ruminative process that moves from topic to topic, never settling, rarely resolving. The person worries about health, finances, relationships, minor inconveniences, and future events, often switching topics the moment one worry is temporarily resolved.

The most useful psychological handle on GAD is intolerance of uncertainty. Most people can tolerate ambiguity reasonably well — "I don't know if this project will go well, but I'll deal with it." People with GAD treat uncertainty itself as threatening. Not knowing whether something bad might happen is experienced as almost as aversive as knowing it will. Worry functions, paradoxically, as an attempt to solve this problem: by running through all possible scenarios, the person feels as if they are doing something about the threat. But worry rarely produces actionable solutions — it produces more worry. The result is a loop: uncertainty → worry → brief false sense of control → more uncertainty → more worry.

A second layer is metacognitive: people with GAD often hold beliefs about their own worry that maintain it. Positive metacognitions ("Worrying helps me prepare, it shows I care") prevent the person from giving up worrying even when it's exhausting. Negative metacognitions ("My worrying is uncontrollable, it will make me crazy") add a layer of anxiety on top of the worry itself — worry about worry. This is sometimes called meta-worry, and it's a key driver of the subjective sense that the worry is out of control. The physical symptoms — muscle tension, sleep disruption, restlessness, difficulty concentrating — are the autonomic correlates of this sustained hyperarousal; the body treats chronic worry as low-grade, continuous threat.

Treatment for GAD reflects its cognitive structure. CBT targets threat overestimation directly — examining the evidence for feared outcomes, building tolerance for uncertain situations through graduated exposure to uncertainty rather than avoidance. Acceptance-based therapies (like ACT) take a different angle: rather than disputing worry content, they aim to change the person's relationship to the worry, reducing the struggle against it. Both approaches implicitly target intolerance of uncertainty. Medication (SSRIs, SNRIs) addresses the hyperarousal component. The high co-occurrence with depression is not coincidental: chronic exhausting worry depletes resources, and the perceived inability to control one's own mind overlaps with the helplessness and hopelessness of depression. Effective treatment typically needs to address both.